Niraparib plus Aromatase Inhibitors (AI) for Germinal Mutated BRCA1/2 (gBRCAm) or Homologous Recombination Deficient (HRd), Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer (ABC): LUZERN Interim Analysis
Niraparib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Niraparib plus Aromatase Inhibitors (AI) for Germinal Mutated BRCA1/2 (gBRCAm) or Homologous Recombination Deficient (HRd), Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer (ABC): LUZERN Interim Analysis ### Output: Niraparib